![]() |
|
|
Vol. 60, Issue 6, 1195-1200, December 2001
2C-Adrenoceptors
from Golgi to Plasma Membrane in Transfected Human Embryonic Kidney 293 Cells
Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, Ohio
| |
Abstract |
|---|
|
|
|---|
Cold-induced vasoconstriction in cutaneous blood vessels is mediated by
increased constrictor activity of vascular
2-adrenoceptors (
2-ARs). In mouse
cutaneous arteries,
2-AR constriction at 37°C is
mediated by
2A-ARs, whereas after cold exposure
(28°C),
2C-ARs are no longer silent and mediate the
remarkable cold-induced augmentation of
2-AR
responsiveness. The goals of the present study were to develop a cell
model of cutaneous thermoregulation and to determine the mechanisms
underlying the thermosensitivity of
2C-ARs. Human embryonic kidney 293 cells were transiently transfected with the mouse
2A- or
2C-AR. In cells expressing
2A-ARs, UK-14,304
(5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine), an
2-AR agonist, inhibited (10 pM) and stimulated (1-10
nM) the accumulation of cAMP evoked by forskolin. Similar responses
were obtained at 37°C and 28°C. In contrast, in cells expressing
2C-ARs, UK-14,304 did not affect forskolin-stimulated
cAMP accumulation at 37°C but did cause a concentration-dependent
inhibitory effect at 28°C. Subcellular fractionation revealed that at
37°C
2C-ARs were localized predominantly to Golgi
compartments, whereas
2A-ARs localized predominantly to
the plasma membrane. After cooling (28°C),
2C-ARs
relocated from Golgi compartments to the plasma membrane, whereas the
2A-AR remained at the plasma membrane. Immunofluorescence microscopy confirmed that, at 37°C,
2A-ARs were localized to the cell surface, whereas
2C-ARs colocalized with a trans-Golgi
marker. Cooling did not affect localization of
2A-ARs,
but shifted
2C-ARs to the cell surface. Moderate cooling, therefore, caused a selective redistribution of
2C-ARs from the Golgi compartments to the cell surface,
allowing the rescue of the
2C-adrenergic functional
response. This mechanism may explain the role of
2-ARs
in thermoregulation of the cutaneous circulation.
| |
Introduction |
|---|
|
|
|---|
2-Adrenoceptors
(
2-ARs) are members of the serpentine G
protein-coupled family of receptors and have been classified by pharmacological and molecular cloning techniques into
2A-AR,
2B-AR, and
2C-AR subtypes (Kobilka et al., 1987
; Regan et
al., 1988
). These subtypes share sequence homology only in the
transmembrane regions and exhibit sufficient structural heterogeneity
in their intra-and extracellular domains to account for their
differential regulation (Saunders and Limbird, 1999
). All
2-AR subtypes couple to
Gi/Go GTP-binding proteins
to effect changes in cellular function via inhibition of adenylyl
cyclase and voltage-gated Ca2+ channels, or
activation of receptor-operated K+ channels
(Limbird, 1988
). Coupling of
2-ARs to
other signal transduction pathways, such as phospholipases
A2, C, and D, and mitogen-activated protein
kinase have also been described (reviewed by Saunders and Limbird,
1999
). Indeed, the
2A-AR subtype can both
inhibit and stimulate adenylyl cyclase activity through coupling to
Gi and Gs, respectively
(Wade et al., 1999
).
Functional
2-ARs are not widely
distributed in the vascular system; they are most prominent in small
arteries and veins (Flavahan et al., 1985
, 1987
; Faber, 1988
; Leech and
Faber, 1996
).
2-AR activity is dramatically
increased in the cutaneous circulation, where these receptors play an
essential role in thermoregulation (Flavahan et al., 1985
; Flavahan and
Vanhoutte, 1986
). Cold-induced vasoconstriction in the cutaneous
circulation is a protective physiological response that acts to reduce
loss of body heat (Vanhoutte, 1980
). Cold exposure causes
vasoconstriction by a reflex increase in sympathetic output of
norepinephrine and by a direct local action to increase the activity of
the adrenergic neurotransmitter (Vanhoutte, 1980
). This latter effect
is mediated by a rapid and selective augmentation of
2-AR activity (Flavahan et al., 1985
; Ekenvall
et al., 1988
; Faber, 1988
). In cutaneous arteries of the mouse tail,
2-AR constriction at 37°C was mediated by
2A-ARs, with no apparent role for
2C-ARs (Chotani et al., 2000
). However, upon
cold exposure (28°C),
2C-ARs were no longer
silent and mediated the remarkable cold-induced augmentation of
2-AR responsiveness. These data implicate the
2C-AR as a putative thermosensor in the vessel
wall and are consistent with the original notion of the
2C-AR as a "silent receptor" (MacDonald et
al., 1997
). Indeed,
2C-ARs are localized to
intracellular compartments in rat fibroblasts at 37°C (Daunt et al.,
1997
).
The goal of the present study was to generate a cell model of cutaneous
vasoconstriction using HEK293 cells transfected with
2A-ARs or
2C-ARs and
to determine the mechanism underlying the thermosensitivity of
2C-ARs.
| |
Experimental Procedures |
|---|
|
|
|---|
Cell Culture and Transfection.
Human embryonic kidney 293 cells (American Type Culture Collection, Manassas, VA) were cultured in
Dulbecco's modifed Eagle's medium containing
penicillin/streptomycin, supplemented with fetal bovine serum (10%) at
37°C in 5% CO2. Murine
2-ARs were subcloned into the pCDNA3
expression vector (gift from B. Kobilka, Stanford University, Stanford,
CA), and cells were transfected when 40% confluent with either
pCDNA3-
2A-AR or
pCDNA3-
2CAR using the FuGENE 6 transfection
reagent (Roche Molecular Biochemicals, Indianapolis, IN). Equal
expression of receptor subtypes was confirmed by immunoblot analyses
and densitometry (major band at 70 kDa:
2A-AR,
1356.3 ± 80.5;
2C-AR, 1420 ± 48.0, arbitrary units, P > 0.05, n = 3).
Measurement of Cellular Cyclic AMP Accumulation.
Cellular
accumulation of cyclic AMP was measured by radioimmunoassay using a
commercial kit (Biomedical Technologies, Inc., Stoughton, MA). Briefly,
transfected 293 cells were grown to 80% confluence in 12-well plates
at 37°C. On the day of the study, cells were incubated in Dulbecco's
modifed Eagle's medium at 37°C or 28°C for 1 h. The
cells were pretreated with 3-isobutyl-1-methylxanthine (0.225 mM, 30 min) at their respective temperatures, before exposure to the
2-AR agonist UK-14,304 (10 pM-10 nM; one
concentration per well) for 1 min, before adding forskolin (3 µM) for
an additional 5 min. After these treatments, the cells were placed on
ice and washed twice with ice-cold phosphate-buffered saline (with
Ca2+/Mg2+), and lysed with
10 mM HCl in EtOH for 30 min. Samples were centrifuged and the
supernatant was collected for measurement of intracellular cAMP
production using a radioimmunoassay 125I-cyclic
AMP kit.
Subcellular Fractionation.
Transfected 293 cells were
harvested by gentle scraping in buffer A (2 ml; 50 mM Tris-HCl, pH 7.5, 1 mM EDTA, 2 mM MgCl2) containing anti-proteases
(15.7 µg/ml each chymostatin, antipain, and pepstatin; 57.7 µg/ml
leupeptin, and 250 µg/ml 4-(2-aminoethyl)benzenesulfonyl fluoride).
Cell homogenates were prepared as described previously (Hurt et al.,
2000
), and centrifuged (1000g, 5 min, 4°C) to remove cell
debris and nuclei. Sucrose (2 M) was added to the postnuclear supernatant to yield a final concentration of sucrose (0.2 M). Each
sample (30 µg of protein) was layered over a discontinuous sucrose
gradient (0.5, 0.9, 1.2, 1.35, 1.5, and 2 M, each at 1.5 ml) and
centrifuged in a SW40Ti rotor (28,000 rpm, 16 h, 4°C; Beckman
Coulter, Fullerton, CA). Ten fractions (1 ml) were collected drop-wise
from the bottom of the tube by piercing with a needle (26G5/8). Proteins were precipitated by the
addition of trichloroacetic acid (100%, 100 µl) and freezing
(
20°C) overnight. After protein extraction with ether/ethanol
(1:1), the fractions were mixed with SDS sample buffer, resolved by
SDS-polyacrylamide gel electrophoresis on 7 or 10% gels, and bands
were quantified by densitometry (Personal Densitometer; Molecular
Dynamics, Sunnyvale, CA).
Indirect Immunofluorescence Microscopy.
293 cells (50,000 cells) were plated on poly(D-lysine)-coated 25-mm
coverslips. Twenty-four hours after attachment, cells were
cotransfected with plasmid DNA encoding either the
2A-AR or
2C-AR (0.5 µg of DNA per coverslip) and pECFP-Golgi vector (1 µg per
coverslip) for 48 h, and then treated as indicated under Results. pECFP-Golgi vector (CLONTECH, Palo Alto, CA)
encodes a fusion protein comprising ECFP and the amino-terminal 81 amino acids of human
1,4-galactosyltransferase, which targets the fusion protein to the trans-medial Golgi. Cells were fixed
in paraformaldehyde (3%, 4°C, 30 min), and processed for microscopic imaging as detailed previously (Moore et al., 1995
). In certain experiments, cells were permeabilized using Triton X-100 (0.2%).
2A- and
2C-ARs were
tagged with the hemagglutinin epitope at their extracellular amino
termini, and comparison of images obtained from permeabilized and
nonpermeabilized cells allowed a distinction between intracellular and
cell surface receptor staining. The concentrations of antibodies used
were: 0.2 µg/100 µl mHA.11 and 0.15 µg/100 µl goat anti-mouse
Cy3. Coverslips were mounted using the Slowfade Light Antifade kit
(Molecular Probes, Eugene, OR) on precleaned glass micro slides
(Corning Glass Works, Corning, NY) and viewed using a Eclipse E800
fluorescent microscope (Nikon, Tokyo, Japan). Images were collected
using Metamorph Software (Universal Imaging Corporation, Downingtown, PA).
Materials. mHA.11 antibody against the HA-epitope was from Berkeley Antibody Co. (Berkeley, CA) and goat anti-mouse Cy3 was from Molecular Probes (Eugene, OR). Cyclic AMP radioimmunoassay kits were purchased from Biochemical Technologies Inc. (Stoughton, MA). Forskolin and 3-isobutyl-1-methylxanthine were from Sigma Chemical Co. (St Louis, MO), UK-14,304 was obtained from Sigma/RBI (Natick, MA), and mastoparan was purchased from Calbiochem (San Diego, CA). Protein assays were performed using the Bradford method (Bio-Rad Laboratories, Hercules, CA).
Statistics. Statistical evaluation of the data was performed by Student's t test for either paired or unpaired observations. When more than two means were compared, analysis of variance was used. If a significant F value was found, Scheffé's test for multiple comparisons was employed to identify differences among groups. Values were considered to be statistically different when P was less than 0.05.
| |
Results |
|---|
|
|
|---|
2-AR-Signaling.
Forskolin-induced accumulation
of cAMP was not statistically different under warm (37°C) and cold
(28°C) conditions in 293 cells expressing
2A-ARs or
2C-ARs, or
in mock transfected cells (Fig. 1). In
mock transfected cells, the
2-AR agonist
UK-14,304 failed to alter the levels of cAMP stimulated by forskolin
under either warm or cold conditions (data not shown). In 293 cells expressing
2A-ARs, UK-14,304 inhibited (10 pM)
and stimulated (1-10 nM) the accumulation of cAMP evoked by forskolin,
and neither effect was altered by lowering the temperature to 28°C
(Fig. 1A). In contrast, in cells expressing
2C-ARs, UK-14,304 (10 pM-10 nM) did not
significantly affect the accumulation of cAMP stimulated by forskolin
(3 µM) at 37°C but did cause a concentration-dependent reduction in
cAMP levels in cells incubated at 28°C (Fig. 1B). Mastoparan (0.1 µM-0.1 mM), a direct activator of the
Gi-protein, caused similar reductions in cAMP
accumulation evoked by forskolin at warm and cold temperatures in
mock-transfected 293 cells (Fig. 1C).
|
Subcellular Fractionation.
Golgi fractions were identified
with an anti-
-COP monoclonal antibody, and plasma membrane fractions
with an anti-Na+-K+-ATPase
-subunit monoclonal antibody. The discontinuous fractionation protocol separated fractions enriched with Golgi membranes (fraction 3, interphase between 0.9 and 0.5 M sucrose) from those fractions enriched
with plasma membranes (fraction 6, interphase between 1.2 and 1.35 M
sucrose) (Fig. 2A). Cooling of cells for
1 h (28°C) did not affect the distribution of Golgi- or plasma
membrane-enriched fractions.
|
2A-ARs (70-kDa
species) was predominantly at the plasma membrane (fraction 6), and
this pattern was not influenced by cooling to 28°C (Fig. 2A).
Therefore, the plasma membrane: Golgi ratio for
2A-ARs was greater than 1 and was not significantly different between warm and cold conditions (Fig. 2B). In
contrast, at 37°C,
2C-ARs (70-kDa species)
were expressed robustly in fraction 3 (Golgi) but to a much lesser
extent in fraction 6 (plasma membrane) (Fig. 2A). Cooling from 37°C
to 28°C, however, resulted in marked diminution of
2C-AR expression in fraction 3 (Golgi), with
concomitant increased receptor expression in fraction 6 (plasma
membrane) (Fig. 2A). Therefore, the plasma membrane/Golgi ratio for
2C-ARs was significantly increased upon cooling (37°C versus 28°C; 0.6 ± 0.01 versus 2.7 ± 0.5;
P < 0.05, n = 3) (Fig. 2B).
Immunofluorescence.
The pECFP-Golgi vector gave a
characteristic perinuclear staining appearance in both nonpermeabilized
and permeabilized cells (Fig. 3, B and E,
and Fig. 4, B and E). Cooling of the
cells did not affect the cellular distribution of the pECFP-Golgi
vector (Fig. 3, H and K, and Fig. 4, H and K).
|
|
2A-ARs were localized to the cell
surface and could be visualized in both nonpermeabilized (Fig. 3A) and
permeabilized cells (Fig. 3D). Cooling from 37°C to 28°C caused no
significant changes in the surface staining pattern of the
2A-ARs (Fig. 3, G and J), although an intense
perinuclear staining signal was also observed in permeabilized cells
(Fig. 3J), which colocalized with pECFP-Golgi vector (Fig. 3L). The
2A-AR cell surface staining was distinct from
that of the pECFP-Golgi vector at both 37oC and
28°C (Fig. 3, C, F, I, and L).
At 37°C,
2C-ARs were not localized to the
cell surface, demonstrating a very weak staining signal in
nonpermeabilized cells (Fig. 4A), and a perinuclear staining pattern in
permeabilized cells (Fig. 4D), which colocalized with the pECFP-Golgi
vector (Fig. 4F). Contrariwise,
2C-ARs showed
a distinct re-localization in response to cooling. In permeabilized
cells,
2C-ARs localized to the Golgi as well
as the plasma membrane (Fig. 4L). This change in localization was most
striking in nonpermeabilized cells, in which receptor staining at the
cell surface (Fig. 4G) was clearly distinct from the pECFP Golgi vector
staining (Fig. 4I).
| |
Discussion |
|---|
|
|
|---|
Constriction of cutaneous blood vessels in response to cooling is
a protective physiological response that acts to reduce loss of body
heat (Vanhoutte, 1980
). Cooling effects a reflex increase in
sympathetic output of norepinephrine and a direct local increase in the
activity of the adrenergic neurotransmitter at smooth muscle cells
(Vanhoutte, 1980
). The direct constrictor response to cold is mediated
at the cellular level by the rapid and selective augmentation of
2-AR activity (Flavahan et al., 1985
; Ekenvall
et al., 1988
; Faber, 1988
). Specifically, it has been shown that
increased activity of
2C-AR function mediates the augmented vasoconstriction to cooling in mouse arterial
microvessels (Chotani et al., 2000
). Thus, the
2C-AR may act as a putative thermosensor in
the vessel wall. The mechanisms by which
2C-ARs become pharmacologically active by cold
exposure are not understood and formed the focus of this study. To this
end, we developed a cell model in which to characterize the
thermosensitivity of the
2C-AR. Indeed,
transfection of HEK293 cells with mouse
2C-ARs, but not
2A-ARs, engendered thermosensitivity in these
cells. We used functional, biochemical, and immunocytochemical
techniques to demonstrate that moderate cooling evoked a selective
recompartmentalization of
2C-ARs from the
Golgi network to the plasma membrane. These changes in the steady-state
distribution of
2C-ARs uncovered a functional
response to agonist stimulation.
Cooling from 37°C to 28°C for brief intervals is sufficient to
uncover
2C-AR-mediated vasoconstriction
(Chotani et al., 2000
). Thus, a similar cooling regimen (28°C for
1 h) was employed to study the effects of lowering temperature on
2-AR responsiveness in a transfected cell
system. In 293 cells transiently expressing
2C-ARs, the
2-AR
agonist UK-14,304 failed to inhibit the accumulation of cAMP stimulated
by forskolin at all concentrations studied at 37°C. Cooling to
28°C, however, uncovered a marked concentration-dependent inhibitory
capacity for UK-14,304. The influence of cooling was selective for the
2C-AR, because the responses to UK-14,304 in 293 cells expressing
2A-ARs were not affected
by changes in temperature.
2A-ARs and the
2C-ARs both inhibit adenylyl cyclase via
activation of Gi-proteins, although
2A-ARs can also couple to
Gs (Eason et al., 1992
) generating biphasic
concentration-effect curves to agonist stimulation (Wade et al., 1999
),
as observed in the present study. A lack of effect of cold on responses
to
2A-AR activation suggests that moderate
cooling does not markedly affect signaling events downstream of
2-ARs. Indeed, responses to direct activation
of adenylyl cyclase by forskolin or to direct activation of
Gi-proteins by mastoparan (Higashijima et al.,
1990
) were not affected by these moderate changes in temperature. These
data implicate the
2C-AR as a specific
thermosensor in transfected HEK293 cells.
Subcellular fractionation of 293 cells expressing
2CARs revealed that the
2C-ARs were localized predominantly to
intracellular Golgi compartments and that, upon cooling, this receptor
subtype translocated to the plasma membrane. In contrast,
2A-ARs were located predominantly at the
plasma membranes at warm and cold temperatures. Both receptor subtypes
were expressed as 70-kDa species, which represents the glycosylated
form of the receptors. Deglycosylation of receptors with PNGase F in a
transfected cell system converted this high-molecular-mass receptor to
a species of smaller mass (40-45 kDa) (Chotani et al., 2000
). Although
the role of glycosylation in the regulation of
2-AR function has not been established, the 70 kDa species may represent the functional form of the receptor. Indeed,
a direct correlation between the level of expression of the
glycosylated receptor species and
2-AR function was observed in mouse tail arterioles (Chotani et al., 2000
).
The fundamental observation that
2C-ARs are
relocated to the cell periphery upon moderate cooling of cells was
confirmed by visualization of epitope-tagged receptors by
immunofluorescence microscopy. At 37°C, substantial colocalization of
2C-ARs with the trans-Golgi marker
pECFP-Golgi vector was observed. Previous studies, however, have
reported that the majority of
2C-ARs expressed in rat fibroblasts at 37°C are confined to the endoplasmic reticulum and cis-medial Golgi compartments (Daunt et al., 1997
). This
discrepancy may be related to the cell system chosen for study, because
the intracellular localization of
2C-ARs is
highly cell-type dependent (Hurt et al., 2000
). For example,
2C-ARs are retained in intracellular compartments in HEK293 cells (this study), COS-7 cells, NRK cells, Madin-Darby canine kidney cells, and rat1 fibroblasts but are localized
to the cell surface in PC12 and AtT20 neuroendocrine cells (Hurt et
al., 2000
). Comparative studies among these cell types may provide
clues as to the mechanism by which
2C-ARs are differentially distributed and regulated and whether such mechanisms are initiated by cooling.
Redistribution of
2C-ARs from the Golgi to the
cell surface did not result from loss of integrity of the cellular
compartments. The subcellular fractionation protocol provided a clean
and reproducible separation of fractions enriched in Golgi or plasma
membranes during both warm and cool conditions. Furthermore,
immunofluorescence microscopy showed that the staining pattern of the
Golgi marker pECFP-Golgi was unaffected by cooling, suggesting that the
integrity of the Golgi remained intact.
Spatial relocation of
2C-ARs to the cell
surface during cooling rescued a functional
2C-AR response. A large pool of functional
2C-ARs, however, is found in the endoplasmic
reticulum of NRK cells, as determined by radioligand binding assay
(Hurt et al., 2000
). The existence of an intracellular store of
functional
2C-ARs may facilitate the rapid
cooling-induced translocation of receptors to the cell surface by
negating the need for further biochemical or structural modification.
Certainly, the size of the receptor protein that undergoes
recompartmentalization in response to cooling is the same in both Golgi
and plasma membrane fractions. Thus, cooling may target
post-translational events in the
2C-AR
biosynthetic pathway. Indeed, inhibition of receptor translation with
cycloheximide does not selectively impair the expression of
2C-ARs in HEK293 cells or the
2C-AR-mediated vasoconstriction to cooling
(unpublished data). A scenario may be imagined, therefore, in which
mature and functional receptors are stored in the Golgi compartments in
readiness for an appropriate translocation stimulus. Interestingly, a
similar mechanism has been described for the mutant cystic fibrosis transmembrane conductance regulator,
F508 CFTR, which is retained in
the endoplasmic reticulum-Golgi compartments but undergoes spatial and
functional rescue by cooling or addition of small solvent chaperones
(Denning et al., 1992
; Brown et al., 1996
). The possibility exists that
both the
2C-AR and cystic fibrosis transmembrane conductance regulator share the same regulatory pathway
in response to cooling.
The selective recruitment of
2C-ARs to the
cell surface during cooling reported here may help explain the
augmented vasoconstrictor response to
2-AR
stimulation observed in the cutaneous microcirculation (Chotani et al.,
2000
). Moreover, these findings highlight the
2C-AR as a potential target for therapeutic
intervention in vascular disorders such as Raynaud's phenomenon, which
is associated with a heightened cold-induced
2-AR vasoconstriction (Freedman et al., 1995
).
In conclusion, this study demonstrates that moderate cooling causes
selective recompartmentalization of
2C-ARs
from the Golgi network to the plasma membrane, where these receptors are responsive to agonist stimulation.
| |
Acknowledgments |
|---|
We thank Dr. Brian Kobilka (Stanford University) for kindly providing the receptor expression plasmids, and Dr. Arthur Strauch (The Ohio State University, Columbus, OH) for assistance with densitometric measurements.
| |
Footnotes |
|---|
Received August 6, 2001; Accepted September 25, 2001
This work was supported by National Institutes of Health Grant AR46126 (to N.A.F.), by The Scleroderma Research Foundation (to N.A.F.), and by the American Heart Association, Ohio Valley Affiliate (to M.A.C.).
Dr. Nicholas A. Flavahan, Ph.D., Dorothy M. Davis Heart and Lung Research Institute, 473 West 12th Avenue, Room 110E, The Ohio State University, Columbus OH 43210. E-mail: flavahan.1{at}osu.edu
| |
Abbreviations |
|---|
AR, adrenoceptor; HEK, human embryonic kidney; UK-14,304, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine.
| |
References |
|---|
|
|
|---|
F508 cystic fibrosis transmembrane conductance regulator protein.
Cell Stress Chaperones
1:
117-125[Medline].
2C-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries.
Am J Physiol
278:
H1075-H1083.
2-adrenergic receptors.
Mol Pharmacol
51:
711-720
2-adrenergic receptors to two G-proteins with opposing effects. Subtype-selective coupling of
2 C10,
2 C4, and
2 C2 adrenergic receptors to Gi and Gs.
J Biol Chem
267:
15795-15801
-1 and
-2 adrenergic responses in canine saphenous and femoral veins.
J Pharmacol Exp Ther
238:
139-147
-1 and
-2 adrenoceptors: differential distribution in arteries of the limbs.
J Pharmacol Exp Ther
241:
361-365
1-adrenergic antagonists in idiopathic Raynaud's disease.
Circulation
92:
1448-1451
2-adrenergic receptor internalization via the constitutive endocytic pathway into rab5-containing endosomes.
J Cell Sci
108:
2983-2991[Abstract].
2-adrenergic receptor subtype.
Proc Natl Acad Sci USA
85:
6301-6305
2-adrenergic receptor subtypes in cells and tissues.
Pharmacol Ther
84:
193-205[Medline].
2A-adrenergic receptors: distinct basic residues mediate Gi versus Gs activation.
Mol Pharmacol
56:
1005-1013This article has been cited by other articles:
![]() |
A. H. Eid, M. A. Chotani, S. Mitra, T. J. Miller, and N. A. Flavahan Cyclic AMP acts through Rap1 and JNK signaling to increase expression of cutaneous smooth muscle {alpha}2C-adrenoceptors Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H266 - H272. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Eid, K. Maiti, S. Mitra, M. A. Chotani, S. Flavahan, S. R. Bailey, C. S. Thompson-Torgerson, and N. A. Flavahan Estrogen increases smooth muscle expression of {alpha}2C-adrenoceptors and cold-induced constriction of cutaneous arteries Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1955 - H1961. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Thompson-Torgerson, L. A. Holowatz, N. A. Flavahan, and W. L. Kenney Cold-induced cutaneous vasoconstriction is mediated by Rho kinase in vivo in human skin Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1700 - H1705. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Johnson Mechanisms of vasoconstriction with direct skin cooling in humans Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1690 - H1691. [Full Text] [PDF] |
||||
![]() |
S. C. Prinster, T. G. Holmqvist, and R. A. Hall {alpha}2C-Adrenergic Receptors Exhibit Enhanced Surface Expression and Signaling upon Association with beta2-Adrenergic Receptors J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 974 - 981. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Hodges, K. Zhao, W. A. Kosiba, and J. M. Johnson The involvement of nitric oxide in the cutaneous vasoconstrictor response to local cooling in humans J. Physiol., August 1, 2006; 574(3): 849 - 857. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Alvarez, K. Zhao, W. A. Kosiba, and J. M. Johnson Relative roles of local and reflex components in cutaneous vasoconstriction during skin cooling in humans J Appl Physiol, June 1, 2006; 100(6): 2083 - 2088. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Krajnak, R. G. Dong, S. Flavahan, D. Welcome, and N. A. Flavahan Acute vibration increases {alpha}2C-adrenergic smooth muscle constriction and alters thermosensitivity of cutaneous arteries J Appl Physiol, April 1, 2006; 100(4): 1230 - 1237. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Bailey, S. Mitra, S. Flavahan, and N. A. Flavahan Reactive oxygen species from smooth muscle mitochondria initiate cold-induced constriction of cutaneous arteries Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H243 - H250. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Herrick Pathogenesis of Raynaud's phenomenon Rheumatology, May 1, 2005; 44(5): 587 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S Thompson, L. A Holowatz, and W. L. Kenney Attenuated noradrenergic sensitivity during local cooling in aged human skin J. Physiol., April 1, 2005; 564(1): 313 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. de Salamanca, K. F. Siemasko, Y. Diebold, M. Calonge, J. Gao, M. Juarez-Campo, and M. E. Stern Expression of Muscarinic and Adrenergic Receptors in Normal Human Conjunctival Epithelium Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 504 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Chotani, S. Mitra, A. H. Eid, S. A. Han, and N. A. Flavahan Distinct cAMP signaling pathways differentially regulate {alpha}2C-adrenoceptor expression: role in serum induction in human arteriolar smooth muscle cells Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H69 - H76. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.R. Bailey, A.H. Eid, S. Mitra, S. Flavahan, and N.A. Flavahan Rho Kinase Mediates Cold-Induced Constriction of Cutaneous Arteries: Role of {alpha}2C-Adrenoceptor Translocation Circ. Res., May 28, 2004; 94(10): 1367 - 1374. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Chotani, S. Mitra, B. Y. Su, S. Flavahan, A. H. Eid, K. R. Clark, C. R. Montague, H. Paris, D. E. Handy, and N. A. Flavahan Regulation of {alpha}2-adrenoceptors in human vascular smooth muscle cells Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H59 - H67. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Kubiak, M. J. Larsen, S. C. Nulf, M. R. Zantello, K. J. Burton, J. W. Bowman, T. Modric, and D. E. Lowery Differential Activation of "Social" and "Solitary" Variants of the Caenorhabditis elegans G Protein-coupled Receptor NPR-1 by Its Cognate Ligand AF9 J. Biol. Chem., September 5, 2003; 278(36): 33724 - 33729. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Philipp, M. Brede, and L. Hein Physiological significance of alpha 2-adrenergic receptor subtype diversity: one receptor is not enough Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2002; 283(2): R287 - R295. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||